Operating Segments and Geographic Area Data (Tables)

12 Months Ended

Oct. 31, 2025

Reconciliation of Operating Profit (Loss) from Segments to Consolidated

The following table presents information about our reportable segments, consistent with reporting to our CODM, as further reconciled to consolidated GAAP financial results:


	2025		2024		2023
Sales
Industrial Precision Solutions	$	1,331,792	$	1,398,912	$	1,297,070
Medical and Fluid Solutions	835,385		695,452		660,316
Advanced Technology Solutions	624,510		595,557		671,246
Total segment sales	2,791,687		2,689,921		2,628,632
Adjusted cost of sales
Industrial Precision Solutions	(521,346)		(566,243)		(533,044)
Medical and Fluid Solutions	(419,853)		(344,040)		(325,334)
Advanced Technology Solutions	(297,208)		(279,297)		(332,506)
Total segment adjusted cost of sales	(1,238,407)		(1,189,580)		(1,190,884)
Adjusted selling and administrative expenses
Industrial Precision Solutions	(340,305)		(334,912)		(296,184)
Medical and Fluid Solutions	(136,966)		(117,007)		(108,212)
Advanced Technology Solutions	(187,421)		(193,298)		(201,275)
Total segment adjusted selling and administrative expenses	(664,692)		(645,217)		(605,671)
Depreciation
Industrial Precision Solutions	23,732		23,012		17,353
Medical and Fluid Solutions	33,118		22,148		19,064
Advanced Technology Solutions	6,708		6,219		7,266
Total segment depreciation	63,558		51,379		43,683
EBITDA
Industrial Precision Solutions	493,873		520,769		485,195
Medical and Fluid Solutions	311,684		256,553		245,834
Advanced Technology Solutions	146,589		129,181		144,731
Total segment EBITDA	952,146		906,503		875,760
Inventory step-up amortization	(3,135)		(7,703)		(8,862)
Acquisition related costs	(2,334)		(13,957)		(19,966)
Severance and other	(19,256)		(17,332)		(5,487)
Divestiture and related charges	(12,545)		—		—
Depreciation and amortization	(150,523)		(136,175)		(111,898)
Corporate expenses	(52,628)		(57,335)		(56,786)
Interest expense	(104,156)		(88,924)		(59,505)
Interest and investment income	3,051		4,913		2,680
Other - net	(12,972)		(4,509)		(597)
Income before taxes	$	597,648	$	585,481	$	615,339

Schedule of Operating Segments, Long Lived Assets

The following table presents additional information about our reportable segments:


	Industrial Precision Solutions		Medical and Fluid Solutions		Advanced Technology Solutions		Corporate		Total
Year ended October 31, 2025
Amortization of intangibles	$	28,762	$	38,469	$	12,033	$	—	$	79,264
Identifiable assets (1	1,858,974		2,201,528		738,762		1,118,417		5,917,681
Property, plant and equipment expenditures	13,754		30,089		6,227		7,990		58,060
Year ended October 31, 2024
Amortization of intangibles	$	28,176	$	35,913	$	12,883	$	—	$	76,972
Identifiable assets (1)	1,698,627		2,252,483		864,073		1,185,783		6,000,966
Property, plant and equipment expenditures	16,924		19,533		4,237		23,716		64,410
Year ended October 31, 2023
Amortization of intangibles	$	9,731	$	35,924	$	14,064	$	—	$	59,719
Identifiable assets (1)	1,732,696		1,532,928		880,675		1,105,471		5,251,770
Property, plant and equipment expenditures	8,854		15,716		4,612		5,401		34,583

(1) Operating segment identifiable assets include notes and accounts receivable net of allowance for doubtful accounts, inventories net of reserves, property, plant and equipment net of accumulated depreciation and goodwill. Corporate assets are principally cash and cash equivalents, deferred income taxes, leases, headquarter facilities and intangible assets.

Sales and Long-lived Asset Information by Geographic Regions

We have significant net sales, measured based on their geographic destination, and long-lived assets in the following geographic areas:


	2025		2024		2023
Net external sales
Americas	$	1,205,830	$	1,178,626	$	1,149,760
Europe	722,221		726,100		682,676
Asia Pacific	863,636		785,195		796,196
Total net external sales	$	2,791,687	$	2,689,921	$	2,628,632
Long-lived assets
Americas	$	433,123	$	465,521	$	328,312
Europe	106,122		113,274		109,428
Asia Pacific	55,147		59,432		61,282
Total long-lived assets	$	594,392	$	638,227	$	499,022